EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Skating the line between general wellness products and regulated devices: strategies and implications

David A Simon, Carmel Shachar, I Glenn Cohen

Journal of Law and the Biosciences · 01.07.2022 · 9 (2)

DOI: 10.1093/jlb/lsac015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Law and the Biosciences, online erschienen am 14.07.2022. Verfasst von David A Simon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School, Cambridge, Massachusetts, USA. Die Arbeit wurde bisher 36-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gordon and Betty Moore Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Health technology is advancing at a rapid clip, with many of these technologies appearing on consumer products like smartphones and tablets. Federal regulators have responded to these changes with a flexible approach that allows firms to manufacture a ‘general wellness product’ (‘GWP’) without being subject to regulation typically applied to ‘devices’ that diagnose or treat a disease or condition. Using currently available medical products and devices from across a spectrum of diseases, we describe how firms can use this existing regulatory framework to develop innovative products by ‘skating the line’ between mostly unregulated GWPs and regulated devices. On the one hand, we find that skating the line offers a variety of benefits, including potential improvements to product development, innovation, and patient access to medical technologies. On the other hand, we show that this technique has potential costs to patient safety, competition, and data sharing. Skating the regulatory line between GWP and devices, in other words, offers important benefits but is not without risks. Any further regulatory action to address such risks should be careful to leave significant unregulated space for product development.

Schlagwörter

Stichwörter der Autor:innen

competitiondevicesdigital healthhealth lawhealth policywellness

Autor:innen und Institutionen

  • Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School, Cambridge, Massachusetts, USA.

Förderung

  • Gordon and Betty Moore Foundation

Zitieren

APA

Simon, D. A., Shachar, C., & Cohen, I. G. (2022). Skating the line between general wellness products and regulated devices: strategies and implications. Journal of Law and the Biosciences, 9(2). https://doi.org/10.1093/jlb/lsac015

Vancouver

Simon DA, Shachar C, Cohen IG. Skating the line between general wellness products and regulated devices: strategies and implications. Journal of Law and the Biosciences. 2022;9(2). doi:10.1093/jlb/lsac015

BibTeX
@article{Simon2022,
  author = {Simon, David A and Shachar, Carmel and Cohen, I Glenn},
  title = {Skating the line between general wellness products and regulated devices: strategies and implications},
  journal = {Journal of Law and the Biosciences},
  year = {2022},
  volume = {9},
  number = {2},
  doi = {10.1093/jlb/lsac015}
}
Kostenlos starten →